Insider Transactions in Q2 2022 at Blueprint Medicines Corp (BPMC)
Insider Transaction List (Q2 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 23
2022
|
Habib J Dable |
BUY
Grant, award, or other acquisition
|
Direct |
3,900
+50.0%
|
-
|
Jun 21
2022
|
Lynn Seely |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+23.61%
|
-
|
Jun 21
2022
|
George Demetri |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+23.61%
|
-
|
Jun 21
2022
|
Alexis Borisy |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+3.62%
|
-
|
Jun 21
2022
|
Mark Alan Goldberg |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+16.24%
|
-
|
Jun 21
2022
|
Nicholas Lydon |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+4.66%
|
-
|
Jun 21
2022
|
Lonnel Coats |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+23.61%
|
-
|
Jun 21
2022
|
Daniella Beckman |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+30.23%
|
-
|
Jun 07
2022
|
L. Becker Hewes CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,155
-10.36%
|
$189,300
$60.0 P/Share
|
Jun 06
2022
|
L. Becker Hewes CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,220
-3.85%
|
$71,980
$59.76 P/Share
|
Jun 06
2022
|
Percy H. Carter CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,908
-6.24%
|
$112,572
$59.76 P/Share
|
May 23
2022
|
Nicholas Lydon |
BUY
Exercise of conversion of derivative security
|
Direct |
10,909
+17.74%
|
$207,271
$19.53 P/Share
|
May 16
2022
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
20,000
-3.37%
|
$1,100,000
$55.44 P/Share
|
May 16
2022
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+4.8%
|
$160,000
$8.44 P/Share
|
Apr 06
2022
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
5,000
-2.66%
|
$350,000
$70.11 P/Share
|
Apr 06
2022
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.59%
|
$75,000
$15.01 P/Share
|